Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in Man
Tóm tắt
The half-life and metabolic clearance rale (MCR) of antipyrine and phenytoin were determined in 14 young [mean age: 28.8 ± 8.3 (SD) years] and in 14 elderly [mean age: 83.5 ±7.1 (SD) years] subjects and correlated with liver volume, which was determined by ultrasonic scanning, to see if an age-dependent difference in drug metabolism could be explained by a reduced liver weight with age. The size of the liver was smaller in the elderly subjects even when related to decreased body surface. A significant decrease in serum albumin in the elderly compared with the younger group was also noted. The half-life of antipyrine was significantly longer in the elderly than in the younger group, 756 ± 318 and 465 ± 110 minutes, respectively, and the MCR was correspondingly lower in the elderly even when calculated per litre of liver volume, 22.8 ± 7.8 and 36.3 ± 8.9ml/minute/L liver volume, respectively. No significant differences in the 2 age groups were found in half-life and total clearance of phenytoin, but a reduced free phenytoin clearance was demonstrated in the elderly (240 ± 92ml/minute/L liver volume) compared with the younger (325 ± 81 ml/minute/L liver volume) group. No significant correlation was found between liver volume and the half-life of antipyrine and phenytoin. However, a significant correlation was demonstrated between liver volume and MCR of antipyrine as well as between total and free clearance of phenytoin. No correlation was found between the half-lives of the 2 drugs, while a significant correlation existed between the clearance values. It is suggested that the age-dependent reduction in drug clearance is due not only to a smaller liver volume, but is also a result of a reduced capacity of the liver microsomes per unit of liver in the elderly. With regard to age-dependent changes in drug metabolism, the protein binding of the actual drug has to be taken into consideration.
Tài liệu tham khảo
Brien, J.F.; Inaba, T. and Kalow, W.: Comparative drug elimination in man — Diphenylhydantoin and amobarbital. European Journal of Clinical Pharmacology 9: 79–83 (1975).
Brodie, B.B.; Axelrod, J.; Soberman, R. and Levy, B.B.: Estimation of antipyrine in biological materials. Journal of Biological Chemistry 179: 25–29 (1949).
Castleden, C.M. and George, C.F.: The effect of ageing on the hepatic clearance of propranolol. British Journal of Clinical Pharmacology 7: 49–54 (1979).
Cunningham, J. L.; Bullen, M.F. and Price Evans, D.A.: The pharmacokinetics of acetanilide and diphenylhydantoin sodium. European Journal of Clinical Pharmacology 7: 461–466 (1974).
Cuny, G.; Royer, R.J.; Mur, J.M.; Serot, J.M.; Faure, G.; Netter. P.; Maillard, A. and Penin, F.: Pharmacokinetics of salicylates in the elderly. Gerontology 25: 49–55 (1979).
Davies, D.S.; Thorgeirsson, S.S.; Breckenridge, A. and Orme, M.: Interindividual differences in rates of drug oxidation in man. Drug Metabolism and Disposition 1: 411–417 (1973).
Halliwell, M.; Homeida, M. and Roberts, C.J.C.: Value of liver volume measurement in the study of antipyrine kinetics in liver disease. British Journal of Clinical Pharmacology 4: 393P–394P (1977).
Hansen, J.M.; Kristensen, M.; Skovsted, L. and Christensen, L.K.: Dicoumarol induced diphenylhydantoin intoxication. Lancet 2: 265–266 (1966).
Hayes, M.J.; Langman, M.J.S. and Short, A.H.: Changes in drug metabolism with increasing age. I. Warfarin binding and plasma proteins. British Journal of Clinical Pharmacology 2: 69–72 (1975a).
Hayes, M.J.; Langman, M J.S. and Short, A.H.: Changes in drug metabolism with increasing age. II Phenytoin clearance and protein binding. British Journal of Clinical Pharmacology 2: 73–79 (1975b).
Houghton, G.W.; Richeas, A. and Leighton, M.: Effects of age, height, weight and sex on serum concentration in epileptic patients. British Journal of Clinical Pharmacology 2: 251–256 (1975).
Johnsen, S.G.; Kampmann, J.P.; Bennett, E.P. and Jørgensen, F.S.: Enzyme induction by oral testosterone. Clinical Pharmacology and Therapeutics 20: 233–237 (1976)
Jori, A.; DiSalle, E. and Quadri, A.: Rate of aminopyrine disappearance from plasma in young and aged humans. Pharmacology 8: 273–279 (1972).
Kadar, D.; Inaba, T.; Endrenyi, L.; Hohnson, G.E. and Kalow, W.: Comparative drug elimination capacity in man —glulethimide, amobarbital, antipyrine and sulfinpyrazone. Clinical Pharmacology and Therapeutics 14: 552–560 (1973).
Kampmann, J.P.; Mortensen, H.B.; Bach, B.; Waldroff, S; Kristensen, M. and Hansen, J.M.: Kinetics of propylthiouracil in the elderly. Acta Medica Scandinavica 624 (Suppl.): 93–98 (1979).
Kato, R.; Vassanelli, P.; Frontino, G. and Chiesara, E.: Variation in activity of liver microsomal drug-metabolising enzymes in rats in relation to age. Biochemical Pharmacology 13: 1037–1051 (1964)
Klotz, U.; Avant, G.R.; Hoyumpa, A.; Schenker, S. and Wilkinson, G.R.: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Journal of Clinical Investigation 55: 347–359 (1975).
Lumholtz, B.; Siersbaek-Nielsen, K.; Skovsted, L.; Kampmann, J.P. and Hansen, J.M.: Sulfamethizole induced inhibition of diphenylhydantoin, tolbutamide and warfarin metabolism. Clinical Pharmacology and Therapeutics 17: 731–734 (1975).
O’Malley, K.; Crooks, J.; Duke, E. and Stevenson, I.H.: Effects of age and sex on human drug metabolism. British Medical Journal 3: 607–609 (1971).
Pirttiaho, H.I.; Sotaniemi, E.A.; Ahokas, J.T. and Pitkänen, U.: Liver size indices of drug metabolism in epileptics. British Journal of Clinical Pharmacology 6: 273–278 (1978).
Rasmussen, S.N.: Liver volume determination by ultrasonic scanning. Danish Medical Bulletin 25: 1–48 (1978)
Rasmussen, S.N.; Hansen, J.M.; Kampmann, J.P.; Skovsted, L. and Bach, B.: Drug metabolism in relation to liver volume and age. Scandinavian Journal of Gastroenterology 11 (Suppl. 38): 82 (1976).
Roberts, C.J.C.; Jackson, L.; Halliwell, M. and Branch, R.A.: The relationship between liver volume, antipyrine clearance and indocyanin green clearance before and after phenobarbitone administration in man. British Journal of Clinical Pharmacology 3: 907–913 (1976).
Rodkey, F.L: Direct spectro-photometric determination of albumin in human serum. Clinical Chemistry 11: 478–487 (1965).
Sato, T.; Miwa, T. and Tauchi, H.: Age changes in the human liver of the different races. Geronlologia 16: 368–380 (1970).
Swift, C.C.; Homeida, M.; Halliwell, M. and Roberts, C.J.C.: Antipyrine disposition and liver size in the elderly. European Journal of Clinical Pharmacology 14: 149–152 (1978)
Traeger, A.; Kunze. H; Stein, G. and Ankermann, H.; Zur Pharmakokinetik von Indometazin bei alten Mänschen. Zeitschrift für Alternforschung 27: 151–155 (1973).
Triggs, E.J.; Nation, R.L.; Long, A. and Ashley, J.J.: Pharmacokinetics in the elderly. European Journal of Clinical Pharmacology 8: 55–62 (1974).
Vesell, E.S. and Page, J.G.: Genetic control of dicoumarol levels in man. Journal of Clinical Investigation 47: 2657–2663 (1968)
Vesell, E.S. and Page, J.G.: Genetic control of drug levels in man: Antipyrine. Science 161: 72–73 (1975)
Vestal, R.E.; Norris, A.H.; Tobin, J.D.; Cohen, B.H.; Shock, N.W. and Andres, R.: Antipyrine metabolism in man: Influence of age, alcohol, caffeine and smoking. Clinical Pharmacology and Therapeutics 18: 425–432 (1975).
Wilkinson, G.R.: The effects of ageing on the disposition of benzodiazepines in man; in Crooks and Stevenson (Eds) Drugs and the Elderly, pp 103–116 (Macmillan, London 1979)
Wilkinson, G.R. and Shand, D.G.: A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975)